Bringing Mass Spectrometry into Your Laboratory:
Critical Considerations for Success
This webcast will review the issues a laboratory faces from both the "hardware" and "human ware" perspectives when deciding if mass spectrometry is a viable technology to bring into a particular laboratory. In addition, the presenters will offer a "must have" checklist of considerations for that labs should review BEFORE moving ahead with their installation plans. We'll also review the latest developments in LC/MS technology designed to make this platform accessible for the clinical laboratory.
Mark Kellogg, PhD, DABCC, FACB
Dr. Kellogg is currently the Associate Director of Chemistry in the Boston Children's Hospital Department of Laboratory Medicine, and also Assistant Professor of Pathology at Harvard Medical School. His clinical research and teaching contributions focus on the discovery, development and validation of biomarkers for clinical diagnostics. His primary interest is development of robust clinical research methods in mass spectrometry applicable to the context of a high-throughput environment. His group has successfully developed and validated methods for cotinine, busulfan, methotrexate, testosterone, free thyroxine, vitamin D and other steroids. Current research projects include the development of a mass spectrometric method for analysis of iohexol ,which is used in determination of glomerular filtration rate; enzymes associated with the metabolism of galactose; and assorted steroid molecules. He has been actively involved in the development of mass spectrometry-based methods for clinical research use since 2003. Dr. Kellogg is active in the American Association for Clinical Chemistry, currently serving as Secretary for the Northeast section, having previously served as section Chair. He is on the executive board for the AACC Nutrition Division and on the boards of the Commission on Accreditation in Clinical Chemistry and the American Board of Clinical Chemistry.
Joseph DiBussolo, PhD
Dr. DiBussolo and is currently a Senior Scientist in the Life Science Mass Spectrometry Division of Thermo Fisher Scientific, having earned his BS degree in clinical chemistry at West Chester University and a PhD in biological sciences from Drexel University in Philadelphia. He has helped develop and support various analytical instruments and software for over 20 years. His primary responsibilities focus on training customers on use of LC/MS instrumentation, collaborating on development of LC/MS methods and managing the Applications Laboratory at West Chester University of Pennsylvania, where he is an adjunct professor and advisor in the University's Pharmaceutical Product Development program.
1.) Identify hurdles to the implementation of mass spectrometry in the laboratory.
2.) Discuss how laboratories can leverage mass spectrometry to improve the depth and quality of their test menu.
3.) Describe key factors to consider before bringing mass spectrometry into your laboratory
4.) Understand how a novel LC/MS solution can make this technology accessible to labs with little or no LC/MS experience.
This webcast is intended for laboratory administrators, directors, and managers; pathologists; clinicians; and IVD industry professionals who are involved in the evaluation, purchase, validation and/or oversight of clinical mass spectrometry systems.
To access this webcast, you will need a computer with Internet access and speakers, a compatible Internet browser (e.g., Internet Explorer), and a compatible version of the Flash plug-in. To see if your browser, Flash plug-in and system meet the minimum requirements please visit the Adobe System Requirements page.